Nucleic Acid Hybrids as Advanced Antibacterial Nanocarriers

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Microbiology

Background:

• Conventional antibiotic therapy faces challenges like poor drug penetration and antimicrobial resistance, impacting public health.
• Nanoparticulate delivery platforms can improve drug targeting and reduce side effects but often suffer from poor loading and release efficiency.
• Nucleic acid hybrid nanocarriers, combining nucleic acids with other materials, show promise for antimicrobial applications but are underutilized.

Purpose of the Study:

• To review fabrication strategies for nucleic acid hybrid nanocarriers.
• To address challenges associated with oligonucleotide nanocarriers.
• To explore the potential of nucleic acid hybrids in combating antimicrobial resistance.

Main Methods:

• Review of fabrication strategies for nucleic acid hybrid nanocarriers.
• Analysis of recent applications in pathogen targeting and drug release control.
• Discussion of challenges and prospects of these nanocarriers.

Main Results:

• Nucleic acid hybrids can overcome limitations of conventional nanocarriers.
• These systems demonstrate potential for enhanced pathogen targeting and controlled drug release.
• They offer a unique strategy to deliver antimicrobials against resistant pathogens and target specific genes.

Conclusions:

• Nucleic acid hybrid nanocarriers represent a promising next-generation antimicrobial strategy.
• Further research into their fabrication and application is crucial for combating antimicrobial resistance.
• These multifunctional nanocarriers hold significant potential for future therapeutic interventions.